Skip to main content
Top
Published in: Supportive Care in Cancer 10/2008

01-10-2008 | Original ARticle

Association between fatigue and other cancer-related symptoms in patients with advanced cancer

Authors: Sriram Yennurajalingam, J. Lynn Palmer, Tao Zhang, Valerie Poulter, Eduardo Bruera

Published in: Supportive Care in Cancer | Issue 10/2008

Login to get access

Abstract

Goals of work

Although fatigue is the chronic symptom most commonly experienced by patients with advanced cancer, little research has been done on the associations and correlates of fatigue in this population. The aim of this study was, therefore, to determine whether fatigue scores, as measured by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), are associated with age, gender, type of cancer diagnosed, pain, and other cancer-related symptoms measured using the Edmonton Symptom Assessment Scale (ESAS).

Materials and methods

We retrospectively reviewed the FACIT-F (when a higher score denotes lower fatigue) and ESAS (when a lower fatigue score denotes lower fatigue intensity) scores of 268 patients with advanced cancer who had been previously enrolled in clinical trials of therapies for fatigue. To determine associations between variables, we performed univariate and multivariate analyses on the data.

Results

We found no univariate association between fatigue score and gender, ethnicity (p = 0.31), or type of cancer diagnosed. Performance status was associated with fatigue (p < 0.0001). On multivariate analysis, we found, however, significant association between fatigue and pain (r = −0.20, p = 0.0012), nausea (r = −0.13, p = 0.04), anxiety (r = −0.27, p < 0.0001), fatigue and depression (r = −0.19, p = 0.0019), drowsiness (r = −0.24, p = 0.0002), dyspnea (r = −0.17, p = 0.007), anorexia (r = −0.29, p < 0.0001), insomnia (r = −0.25, p < 0.0001), and feelings of well-being (r = −0.37, p < 0.0001). Using backward stepwise logistic regression analysis, independent correlative factors associated with fatigue include well-being (p = .0003), drowsiness (0.006), anorexia (0.01), and anxiety (0.03). However, this model only explained 21% of the variation in the intensity of fatigue.

Conclusions

Although we found that fatigue is significantly associated with the severity of psychological symptoms (anxiety and depression) and physical symptoms (pain, dyspnea, insomnia, anorexia, and drowsiness), additional research is required to confirm that these are indeed the main associations of fatigue and, by doing so, enable physicians to better characterize fatigue in patients receiving palliative care.
Literature
1.
go back to reference Bower JE, Ganz PA, Desmond KA et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed Bower JE, Ganz PA, Desmond KA et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed
2.
go back to reference Brown DJ, McMillan DC, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103:377–382PubMedCrossRef Brown DJ, McMillan DC, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103:377–382PubMedCrossRef
3.
go back to reference Bruera E, Driver L, Barnes EA et al (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21:4439–4443PubMedCrossRef Bruera E, Driver L, Barnes EA et al (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21:4439–4443PubMedCrossRef
4.
go back to reference Bruera E, El Osta B, Valero V et al (2007) Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475–3481PubMedCrossRef Bruera E, El Osta B, Valero V et al (2007) Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475–3481PubMedCrossRef
5.
go back to reference Bruera E, Kuehn N, Miller MJ et al (1991) The Edmonton Symptom Assessment Scale (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ et al (1991) The Edmonton Symptom Assessment Scale (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
6.
go back to reference Bruera E, Miller L, McCallion J et al (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192–195PubMedCrossRef Bruera E, Miller L, McCallion J et al (1992) Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7:192–195PubMedCrossRef
7.
go back to reference Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073–2078PubMedCrossRef Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073–2078PubMedCrossRef
8.
go back to reference Cella D, Davis K, Breitbart W, Curt GA (2001) Fatigue coalition: cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391PubMed Cella D, Davis K, Breitbart W, Curt GA (2001) Fatigue coalition: cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391PubMed
9.
go back to reference Cella D, Lai JS, Chang CH et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2:528–538CrossRef Cella D, Lai JS, Chang CH et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2:528–538CrossRef
10.
go back to reference Cella D (1997) Manual of the Functional Assessment of Chronic illness Therapy (FACIT) Measurement System. Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University. Version 4. Cella D (1997) Manual of the Functional Assessment of Chronic illness Therapy (FACIT) Measurement System. Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University. Version 4.
11.
go back to reference Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
12.
go back to reference Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164–2171PubMedCrossRef Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164–2171PubMedCrossRef
13.
go back to reference Curt GA, Breitbart W, Cella D (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMedCrossRef Curt GA, Breitbart W, Cella D (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMedCrossRef
14.
go back to reference Echteld MA, Passchier J, Teunissen S et al (2007) Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer 6:1030–1036CrossRef Echteld MA, Passchier J, Teunissen S et al (2007) Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer 6:1030–1036CrossRef
15.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198CrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198CrossRef
16.
go back to reference Given CW, Given B, Azzouz F et al (2001) Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21:456–466PubMedCrossRef Given CW, Given B, Azzouz F et al (2001) Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21:456–466PubMedCrossRef
17.
go back to reference Glaus A, Crow R, Hammond S (1996) A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 2:82–96CrossRef Glaus A, Crow R, Hammond S (1996) A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 2:82–96CrossRef
18.
go back to reference Hwang SS, Chang VT, Montse R et al (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 26:604–614PubMedCrossRef Hwang SS, Chang VT, Montse R et al (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 26:604–614PubMedCrossRef
19.
go back to reference Mallinson T, Cella D, Cashy J et al (2006) Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage 31:229–241PubMedCrossRef Mallinson T, Cella D, Cashy J et al (2006) Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage 31:229–241PubMedCrossRef
20.
go back to reference Munch TN, Zhang T, Willey J et al (2005) The association between anemia and fatigue in patients with advanced cancer receiving palliative care. J Palliat Med 8:1144–1149PubMedCrossRef Munch TN, Zhang T, Willey J et al (2005) The association between anemia and fatigue in patients with advanced cancer receiving palliative care. J Palliat Med 8:1144–1149PubMedCrossRef
21.
go back to reference National Comprehensive Cancer Network Practice Guidelines (2006) Cancer-related fatigue panel 2006 guidelines, version 1. National Comprehensive Cancer Network Practice Guidelines (2006) Cancer-related fatigue panel 2006 guidelines, version 1.
22.
go back to reference Radbruch L, Strasser F, Elsner F et al (2008) Fatigue in palliative care patients—an EAPC approach. Palliat Med 22:13–32PubMedCrossRef Radbruch L, Strasser F, Elsner F et al (2008) Fatigue in palliative care patients—an EAPC approach. Palliat Med 22:13–32PubMedCrossRef
23.
go back to reference Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275–290PubMed Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275–290PubMed
24.
go back to reference Respini D, Jacobsen PB, Thors C et al (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273–279PubMedCrossRef Respini D, Jacobsen PB, Thors C et al (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273–279PubMedCrossRef
25.
go back to reference Romito F, Montanaro R, Corvasce C et al (2007) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer DOI 10.1007/s00520-007-0357-1 Romito F, Montanaro R, Corvasce C et al (2007) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer DOI 10.​1007/​s00520-007-0357-1
26.
go back to reference Stone P, Richards M, A’Hern R et al (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 5:561–567CrossRef Stone P, Richards M, A’Hern R et al (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 5:561–567CrossRef
27.
go back to reference Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34:S4–12 Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34:S4–12
28.
go back to reference Wang XS, Giralt SA, Mendoza TR et al (2002) Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol 5:1319–1328CrossRef Wang XS, Giralt SA, Mendoza TR et al (2002) Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol 5:1319–1328CrossRef
29.
go back to reference Yennurajalingam S, Bruera E (2007) Palliative management of fatigue at the close of life: “It feels like my body is just worn out.” JAMA 297:295–304PubMedCrossRef Yennurajalingam S, Bruera E (2007) Palliative management of fatigue at the close of life: “It feels like my body is just worn out.” JAMA 297:295–304PubMedCrossRef
Metadata
Title
Association between fatigue and other cancer-related symptoms in patients with advanced cancer
Authors
Sriram Yennurajalingam
J. Lynn Palmer
Tao Zhang
Valerie Poulter
Eduardo Bruera
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0466-5

Other articles of this Issue 10/2008

Supportive Care in Cancer 10/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine